Summit Therapeutics Inc. Annual Amortization of Intangible Assets in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Summit Therapeutics Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from 2017 to 2024.
  • Summit Therapeutics Inc. Amortization of Intangible Assets for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Summit Therapeutics Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Summit Therapeutics Inc. annual Amortization of Intangible Assets for 2024 was $0.000.
  • Summit Therapeutics Inc. annual Amortization of Intangible Assets for 2023 was $0.000, a 100% decline from 2022.
  • Summit Therapeutics Inc. annual Amortization of Intangible Assets for 2022 was $914K, a 10.1% decline from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 Jan 1, 2024 Dec 31, 2024 10-K 2025-02-24
2023 $0 -$914K -100% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-24
2022 $914K -$103K -10.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-24
2021 $1.02M -$233K -18.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.25M +$250K +25% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 $1M -$100K -9.09% Jan 1, 2019 Dec 31, 2019 10-Q 2020-11-16
2018 $1.1M +$963K +703% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $137K Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.